{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:15:56Z","timestamp":1763399756228,"version":"3.37.3"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175007"],"award-info":[{"award-number":["175007"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jgar.2017.11.005","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:48:40Z","timestamp":1510706920000},"page":"60-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to \u03b2-lactams and carbapenems in patients with healthcare-associated infections"],"prefix":"10.1016","volume":"13","author":[{"given":"Zorana M.","family":"Djordjevic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko M.","family":"Folic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1519-8828","authenticated-orcid":false,"given":"Slobodan M.","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2017.11.005_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.diagmicrobio.2013.11.025","article-title":"Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009\u20132011)","volume":"78","author":"Sader","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2017.11.005_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009\u20132010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2017.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/CCM.0b013e31819ced02","article-title":"Review of studies of the impact on Gram-negative bacterial resistance on outcomes in the intensive care unit","volume":"37","author":"Shorr","year":"2009","journal-title":"Crit Care Med"},{"year":"2014","series-title":"Antimicrobial resistance: global report on surveillance 2014","author":"World Health Organization","key":"10.1016\/j.jgar.2017.11.005_bib0020"},{"key":"10.1016\/j.jgar.2017.11.005_bib0025","article-title":"Surveillance and correlation of antimicrobial usage and resistance of Pseudomonas aeruginosa: a hospital population-based study","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2017.11.005_bib0030","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/jcpt.12432","article-title":"Correlation between antimicrobial consumption and antimicrobial resistance of Pseudomonas aeruginosa in a hospital setting: a 10-year study","volume":"41","author":"Mladenovic-Antic","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jgar.2017.11.005_bib0035","series-title":"Guidelines for ATC classification and DDD assignment 2013","first-page":"165","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"2012"},{"key":"10.1016\/j.jgar.2017.11.005_bib0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jgar.2017.11.005_bib0045","series-title":"Manual of clinical microbiology","first-page":"517","article-title":"Pseudomonas and Burkholderia","author":"Kiska","year":"1995"},{"year":"2014","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement. Document M100-S24","author":"Clinical and Laboratory Standards Institute","key":"10.1016\/j.jgar.2017.11.005_bib0050"},{"issue":"561","key":"10.1016\/j.jgar.2017.11.005_bib0055","first-page":"e7","article-title":"Systematic review of antibiotic consumption in acute care hospitals","volume":"22","author":"Bitterman","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2017.11.005_bib0060","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2298\/SARH1610490D","article-title":"Risk factors for healthcare-acquired urinary tract infections caused by multi-drug resistant microorganisms","volume":"144","author":"Djordjevi\u0107","year":"2016","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.jgar.2017.11.005_bib0065","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/AAC.05560-11","article-title":"Changes in the use of broad-spectrum antibiotics after cefepime shortage: a time series analysis","volume":"56","author":"Pl\u00fcss-Suard","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2017.11.005_bib0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1590\/S1413-86702007000200022","article-title":"Cefepime restriction improves Gram-negative overall resistance patterns in neonatal intensive care unit","volume":"11","author":"Ribeiro de Araujo","year":"2007","journal-title":"Braz J Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.jgar.2017.11.005_bib0075","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/cc6820","article-title":"Gram-negative antibiotic resistance: there is a price to pay","volume":"12","author":"Slama","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.jgar.2017.11.005_bib0080","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3855\/jidc.3516","article-title":"Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection in a tertiary care hospital in Serbia","volume":"7","author":"Djordjevic","year":"2013","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2017.11.005_bib0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1128\/CMR.00001-13","article-title":"Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance","volume":"26","author":"Schechner","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2017.11.005_bib0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/664763","article-title":"Decreased resistance of Pseudomonas aeruginosa with restriction of ciprofloxacin in a large teaching hospital\u2019s intensive care and intermediate care units","volume":"33","author":"Lewis","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2017.11.005_bib0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/0885066615619895","article-title":"Antimicrobial resistance in the intensive care unit: a focus on Gram-negative bacterial infections","volume":"32","author":"MacVane","year":"2017","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jgar.2017.11.005_bib0100","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/cid\/cit152","article-title":"10 \u00d7 \u201820 progress\u2014development of new drugs active against Gram-negative bacilli: an update from the Infectious Diseases Society of America","volume":"56","author":"Boucher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2017.11.005_bib0105","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"year":"2013","series-title":"Antibiotic resistance threats in the United States, 2013","author":"US Centers for Disease Control and Prevention","key":"10.1016\/j.jgar.2017.11.005_bib0110"},{"key":"10.1016\/j.jgar.2017.11.005_bib0115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.15585\/mmwr.mm6430a4","article-title":"Vital signs: estimated effects of a coordinated approach for action to reduce antibiotic-resistant infections in health care facilities\u2014United States","volume":"64","author":"Slayton","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517302163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716517302163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T08:42:17Z","timestamp":1658306537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716517302163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":23,"alternative-id":["S2213716517302163"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2017.11.005","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between cefepime utilisation and Pseudomonas aeruginosa resistance rates to \u03b2-lactams and carbapenems in patients with healthcare-associated infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2017.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}